Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.43
+0.07 (1.31%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $435.51 million as of August 21, 2026. Its market cap has increased by 56.80% in one year.
Market Cap
435.51M
Enterprise Value
216.47M
1-Year Change
56.80%
Ranking
Category
Stock Price
$5.43
ChartMarket Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $435.51M, a decrease of -77.53%. That is a compound annual growth rate of -22.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 435.51M | 56.15% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 471.36M |
| Benitec Biopharma | 463.10M |
| EyePoint | 458.65M |
| Eupraxia Pharmaceuticals | 445.15M |
| Larimar Therapeutics | 436.32M |
| Inhibikase Therapeutics | 435.16M |
| Compass Therapeutics | 432.21M |
| Foghorn Therapeutics | 419.85M |